Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Impairments in dyspnea, exercise capacity, physical activity and quality of life of allogeneic hematopoietic stem cell transplantation survivors compared with healthy individuals: a cross sectional study.

Boşnak Güçlü M, Barğı G, Sucak GT.

Physiother Theory Pract. 2019 Apr 8:1-12. doi: 10.1080/09593985.2019.1594473. [Epub ahead of print]

PMID:
30958713
2.

The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey.

Akı ŞZ, Sucak GT, Tunçcan ÖG, Köktürk N, Şenol E.

Transpl Infect Dis. 2018 Aug;20(4):e12912. doi: 10.1111/tid.12912. Epub 2018 May 9.

PMID:
29679523
3.

Transplant results in adults with Fanconi anaemia.

Bierings M, Bonfim C, Peffault De Latour R, Aljurf M, Mehta PA, Knol C, Boulad F, Tbakhi A, Esquirol A, McQuaker G, Sucak GA, Othman TB, Halkes CJM, Carpenter B, Niederwieser D, Zecca M, Kröger N, Michallet M, Risitano AM, Ehninger G, Porcher R, Dufour C; EBMT SAA WP.

Br J Haematol. 2018 Jan;180(1):100-109. doi: 10.1111/bjh.15006. Epub 2017 Nov 2.

PMID:
29094350
4.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N.

Bone Marrow Transplant. 2017 Jul;52(7):1081. doi: 10.1038/bmt.2017.86.

PMID:
28677682
5.

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T, Snowden JA, Timurağaoğlu A, Dechow T, Lang A, Tuğlular T, Drach J, Armbrecht G, Potamianou A, Couturier C, Olie RA, Feys C, Allietta N, Terpos E.

Br J Haematol. 2017 Jul;178(1):61-71. doi: 10.1111/bjh.14637. Epub 2017 Apr 6.

PMID:
28382618
6.

Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

Özkurt ZN, Sucak GT, Akı ŞZ, Yağcı M, Haznedar R.

Cancer Invest. 2017 Mar 16;35(3):195-201. doi: 10.1080/07357907.2016.1270958. Epub 2017 Jan 23.

PMID:
28112977
7.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N.

Bone Marrow Transplant. 2017 Feb;52(2):209-215. doi: 10.1038/bmt.2016.266. Epub 2016 Nov 7. Erratum in: Bone Marrow Transplant. 2017 Jul;52(7):1081.

PMID:
27819688
8.

Peripheral and bone marrow CD34+ cell levels on chronic myeloproliferative disease.

Pamukcuoglu M, Acar K, Celik B, Akyurek N, Pepeler MS, Sucak GT.

Hematology. 2017 Mar;22(2):74-80. doi: 10.1080/10245332.2016.1232546. Epub 2016 Sep 22.

PMID:
27658882
9.

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.

van Gorkom G, Finel H, Giebel S, Pohlreich D, Shimoni A, Ringhoffer M, Sucak G, Schaap N, Dreger P, Sureda A, Schouten HC.

J Clin Apher. 2017 Oct;32(5):295-301. doi: 10.1002/jca.21506. Epub 2016 Sep 10.

PMID:
27614935
10.

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party.

Necchi A, Miceli R, Bregni M, Bokemeyer C, Berger LA, Oechsle K, Schumacher K, Kanfer E, Bourhis JH, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P, Lanza F.

Bone Marrow Transplant. 2016 Mar;51(3):384-90. doi: 10.1038/bmt.2015.300. Epub 2015 Dec 7.

PMID:
26642334
11.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.

Cahu X, Labopin M, Giebel S, Aljurf M, Kyrcz-Krzemien S, Socié G, Eder M, Bonifazi F, Bunjes D, Vigouroux S, Michallet M, Stelljes M, Zuckerman T, Finke J, Passweg J, Yakoub-Agha I, Niederwieser D, Sucak G, Sengeløv H, Polge E, Nagler A, Esteve J, Mohty M; Acute Leukemia Working Party of EBMT.

Bone Marrow Transplant. 2016 Mar;51(3):351-7. doi: 10.1038/bmt.2015.278. Epub 2015 Nov 30.

PMID:
26618548
12.

Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.

Marchand T, Lamy T, Finel H, Arcese W, Choquet S, Finke J, Huynh A, Irrera G, Karakasis D, Konopacki J, Lambert J, Michieli M, Schouten HC, Schroyens W, Sucak G, Tischer J, Vandenberghe E, Dreger P.

Leukemia. 2016 May;30(5):1201-4. doi: 10.1038/leu.2015.256. Epub 2015 Sep 22. No abstract available.

PMID:
26460210
13.

Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial.

Barğı G, Güçlü MB, Arıbaş Z, Akı ŞZ, Sucak GT.

Support Care Cancer. 2016 Feb;24(2):647-659. doi: 10.1007/s00520-015-2825-3. Epub 2015 Jul 2.

PMID:
26135532
14.

High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation.

Fox CP, Boumendil A, Schmitz N, Finel H, Luan JJ, Sucak G, Blaise D, Finke J, Pflüger KH, Veelken H, Gorin NC, Poiré X, Ganser A, Dreger P, Sureda A.

Leuk Lymphoma. 2015;56(12):3295-300. doi: 10.3109/10428194.2015.1037764. Epub 2015 Aug 26.

PMID:
25899403
15.

Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, Nordic and Turkish myeloma study groups.

Beksac M, Waage A, Bringhen S, Kristinsson SY, Sucak GT, Gimsing P, Lupparelli G, Fıratlı-Tuğlular T, Juliusson G, Turesson I, Palumbo A.

Acta Haematol. 2015;133(4):372-80. doi: 10.1159/000370023. Epub 2015 Mar 24.

16.

Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.

Akı ŞZ, Suyanı E, Cengiz M, Özenirler S, Elbeğ Ş, Paşaoğlu H, Sucak GT.

Biol Blood Marrow Transplant. 2015 May;21(5):948-53. doi: 10.1016/j.bbmt.2015.02.002. Epub 2015 Feb 11.

17.

A rare case of acute leukemia relapsing with a granulocytic sarcoma causing ectopic pregnancy.

Pamukçuoğlu M, Acar K, Akyürek N, Sucak GT.

Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):84-5. doi: 10.1007/s12288-013-0256-1. Epub 2013 Apr 26.

18.

Inflammatory markers, oxidative stress, and antioxidant capacity in healthy allo-HSCT donors during hematopoietic stem cell mobilization.

İlhan Ç, Suyanı E, Sucak GT, Paşaoğlu ÖT, Akı ŞZ, Paşaoğlu H.

J Clin Apher. 2015 Aug;30(4):197-203. doi: 10.1002/jca.21361. Epub 2014 Sep 30.

PMID:
25270291
19.

The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.

Yegin ZA, İyidir ÖT, Demirtaş C, Suyanı E, Yetkin İ, Paşaoğlu H, İlhan Ç, Sucak GT.

J Endocrinol Invest. 2015 Mar;38(3):333-8. doi: 10.1007/s40618-014-0174-6. Epub 2014 Sep 23.

PMID:
25245337
20.

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party.

Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise D, Milpied N, Sucak G, Sureda A, Thomson K, Vandenberghe E, Vitek A, Dreger P; Lymphoma Working Party of the EBMT.

Leukemia. 2015 Mar;29(3):686-8. doi: 10.1038/leu.2014.280. Epub 2014 Sep 19.

PMID:
25234166
21.

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.

Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin Z, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B.

Ann Hematol. 2015 Mar;94(3):415-20. doi: 10.1007/s00277-014-2215-9. Epub 2014 Sep 18.

22.

Recurrent Transient Ischemic Attacks in a Patient with POEMS Syndrome.

Akyol A, Nazliel B, Batur Caglayan HZ, Oner Y, Sucak GT.

Case Rep Neurol Med. 2014;2014:158471. doi: 10.1155/2014/158471. Epub 2014 Mar 4.

23.

The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis.

Boyacı N, Aygencel G, Turkoglu M, Yegin ZA, Acar K, Sucak GT.

Hematology. 2014 Sep;19(6):338-45. doi: 10.1179/1607845413Y.0000000130. Epub 2014 Jan 3.

PMID:
24620953
24.

Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections.

Pamukçuoğlu M, Emmez H, Tunçcan OG, Oner AY, Cırak MY, Senol E, Sucak GT.

Hematology. 2014 Apr;19(3):158-62. doi: 10.1179/1607845413Y.0000000108. Epub 2013 Nov 25.

PMID:
23906027
25.

Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study.

Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Ozdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC.

Acta Haematol. 2013;130(3):199-205. doi: 10.1159/000351172. Epub 2013 Jun 19.

PMID:
23797290
26.

Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.

Yaşar DG, Suyanı E, Özenirler S, Sucak GT.

Transplant Proc. 2013 Mar;45(2):833-4. doi: 10.1016/j.transproceed.2012.06.082.

PMID:
23498831
27.

TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia.

Yağcı M, Yegin ZA, Akyürek N, Kayhan H, Ozkurt ZN, Sucak GT, Haznedar R.

Leuk Res. 2013 Jun;37(6):665-70. doi: 10.1016/j.leukres.2013.01.005. Epub 2013 Feb 21.

PMID:
23434429
28.

Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey.

Sucak GT, Çakar MK, Suyanı E, Akı Z, Altındal Ş, Acar K.

Hematology. 2013 Sep;18(5):269-76. doi: 10.1179/1607845412Y.0000000063. Epub 2013 Jan 25.

PMID:
23394351
29.

Tumor-associated macrophages as a prognostic parameter in multiple myeloma.

Suyanı E, Sucak GT, Akyürek N, Sahin S, Baysal NA, Yağcı M, Haznedar R.

Ann Hematol. 2013 May;92(5):669-77. doi: 10.1007/s00277-012-1652-6. Epub 2013 Jan 20.

PMID:
23334187
30.

Acute respiratory distress syndrome in patients with hematological malignancies.

Türkoğlu M, Erdem GU, Suyanı E, Sancar ME, Yalçın MM, Aygencel G, Akı Z, Sucak G.

Hematology. 2013 May;18(3):123-30. doi: 10.1179/1607845412Y.0000000038. Epub 2012 Nov 15.

PMID:
23321772
31.

Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT.

Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A.

Bone Marrow Transplant. 2013 Jun;48(6):878-9. doi: 10.1038/bmt.2012.255. Epub 2013 Jan 7. No abstract available.

PMID:
23292242
32.

HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey.

Çakar MK, Suyani E, Sucak GT, Altindal Ş, Aki SZ, Acar K, Yağci M, Rota S, Özenirler S.

Ann Hematol. 2013 Mar;92(3):395-402. doi: 10.1007/s00277-012-1620-1. Epub 2012 Nov 11.

PMID:
23143119
33.

Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation.

Akı ŞZ, Suyanı E, Bildacı Y, Çakar MK, Baysal NA, Sucak GT.

Clin Transplant. 2012 Sep-Oct;26(5):E513-21. doi: 10.1111/ctr.12028.

PMID:
23061760
34.

Encephalopathy: an unusual neurologic complication of autologous hematopoietic stem cell transplant in patients with multiple myeloma with renal failure.

Akı SZ, Pamukçuoğlu M, Bağrıaçık Ü, Sucak GT.

Leuk Lymphoma. 2013 Apr;54(4):894-6. doi: 10.3109/10428194.2012.721545. Epub 2012 Nov 6. No abstract available.

PMID:
23039261
35.

Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion.

Yenicesu I, Sucak G, Dilsiz G, Akı SZ, Yeğin ZA.

Indian J Hematol Blood Transfus. 2011 Sep;27(3):146-51. doi: 10.1007/s12288-011-0078-y. Epub 2011 Jun 5.

36.

Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT.

Haematologica. 2013 Mar;98(3):339-45. doi: 10.3324/haematol.2012.071944. Epub 2012 Aug 28.

37.

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.

Palumbo A, Waage A, Hulin C, Beksac M, Zweegman S, Gay F, Gimsing P, Leleu X, Wijermans P, Sucak G, Pezzatti S, Juliusson G, Pégourié B, Schaafsma M, Galli M, Turesson I, Kolb B, van der Holt B, Baldi I, Rolke J, Ciccone G, Wetterwald M, Lokhorst H, Boccadoro M, Rodon P, Sonneveld P.

Haematologica. 2013 Jan;98(1):87-94. doi: 10.3324/haematol.2012.067058. Epub 2012 Aug 8.

38.

Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?

Aydoğdu M, Ozyilmaz E, Köktürk N, Yeğin ZA, Özkurt ZN, Aki ZS, Sucak G.

Minerva Med. 2012 Jun;103(3):189-98.

PMID:
22653099
39.

Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning?

Suyanı E, Altındal Ş, Akı Ş, Sucak GT.

Clin Transplant. 2012 Mar-Apr;26(2):E85-6. doi: 10.1111/j.1399-0012.2012.01616.x. Epub 2012 Mar 20. No abstract available.

PMID:
22429164
40.

The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation.

Sucak GT, Yaşar DG, Yegin ZA, Ergün MA, Ozkurt ZN, Aki ŞZ, Güntekin S.

Ann Hematol. 2012 Aug;91(8):1281-7. doi: 10.1007/s00277-012-1428-z. Epub 2012 Feb 24.

PMID:
22362121
41.

Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010.

Suyanı E, Sucak GT, Erten Y, Cakar MK, Ulusal G, Yağcı M, Haznedar R.

Ren Fail. 2012;34(2):257-62. doi: 10.3109/0886022X.2011.647205. Epub 2012 Jan 20.

PMID:
22260636
42.

The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning.

Sucak GT, Suyanı E, Baysal NA, Altındal Ş, Çakar MK, Akı ŞZ, Yeğin ZA, Şanlıer N.

Int J Hematol. 2012 Jan;95(1):95-101. doi: 10.1007/s12185-011-0980-y. Epub 2011 Dec 9.

PMID:
22160835
43.

TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells.

Bagriacik EU, Yaman M, Haznedar R, Sucak G, Delibasi T.

J Endocrinol. 2012 Feb;212(2):169-78. doi: 10.1530/JOE-11-0404. Epub 2011 Nov 29.

PMID:
22128326
44.

Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.

Akı SZ, Paşaoğlu H, Yeğin ZA, Suyanı E, Demirtaş CY, Ozkurt ZN, Yağcı M, Sucak GT.

Hematology. 2011 Sep;16(5):284-90. doi: 10.1179/102453311X13085644680023.

PMID:
21902892
45.

Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.

Suyanı E, Yağcı M, Sucak GT.

Acta Haematol. 2011;126(4):199-201. doi: 10.1159/000329896. Epub 2011 Aug 18. No abstract available.

PMID:
21849771
46.

[Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in the clinical samples of patients with high risk].

Rota S, Fidan K, Bozdayı G, Dalgıç A, Fidan I, Sucak G, Müderris T.

Mikrobiyol Bul. 2011 Apr;45(2):280-7. Turkish.

PMID:
21644071
47.

Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.

Tunçcan ÖG, Aki ŞZ, Akyürek N, Sucak G, Şenol E.

J Infect Dev Ctries. 2011 May 28;5(5):406-9.

48.

Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.

Sucak GT, Aki SZ, Yüzbaşioğlu B, Akyürek N, Yağci M, Bağriaçik U, Haznedar R.

Leuk Lymphoma. 2011 Jul;52(7):1281-9. doi: 10.3109/10428194.2011.569695. Epub 2011 May 23.

PMID:
21599578
49.

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.

Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation; Infectious Complications Subcommittee, Spanish Group of Haematopoietic Stem-cell Transplantation.

Haematologica. 2011 Aug;96(8):1231-5. doi: 10.3324/haematol.2011.041913. Epub 2011 May 5.

50.

Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival.

Sucak GT, Özkurt ZN, Suyani E, Yaşar DG, Akdemir ÖÜ, Aki Z, Yeğin ZA, Yağci M, Kapucu ÖL.

Ann Hematol. 2011 Nov;90(11):1329-36. doi: 10.1007/s00277-011-1209-0. Epub 2011 Mar 25.

PMID:
21437590

Supplemental Content

Support Center